Product Information

MIRABEGRON ER 50 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $8.9858 per EA under NDC 70710116003. Its NADAC has been published 127 times since Jun 19, 2024.

FDA first approved this application on Sep 29, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MIRABEGRON ER 50 MG TABLET

Mirabegron
$8.9858per EA

Strength

50 mg/1

NDC

70710116003

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MIRABEGRON

Approval Type

Generic (ANDA)

FDA Application

ANDA209488

FDA Approved

9/29/2022

TE Code

AB

On Market Since

1/23/2024

Pharmacological Classes

Adrenergic beta3-Agonists
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors
beta3-Adrenergic Agonist

Price Statistics

The NADAC for MIRABEGRON ER 50 MG TABLET has been published 127 times since Jun 19, 2024, and over the history we have for it it has declined 24.8%. The table below summarizes its recorded NADAC range and movement.

Current price$8.9858 per EA
All-time high$11.9419 (Jul 10, 2024)
All-time low$8.9858 (Nov 18, 2026)
52-week high$9.7568
52-week low$8.9858
Median price$9.7353
Average price$9.9872
Largest weekly change-22.3% (Jul 17, 2024)
Weeks tracked127
Tracking sinceJun 19, 2024

Price History

1W

-1.8%

1M

-4.3%

3M

-6.4%

6M

-7.7%

1Y

-6.1%

3Y

N/A

5Y

N/A

All

-24.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MIRABEGRON ER 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MIRABEGRON ER 50 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $8.9858 per EA (NDC 70710116003), effective Nov 18, 2026.

How has the price of MIRABEGRON ER 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for MIRABEGRON ER 50 MG TABLET has declined 24.8%. It has been tracked across 127 weekly CMS publications since Jun 19, 2024.

What are the highest and lowest recorded NADAC prices for MIRABEGRON ER 50 MG TABLET?

Since Jun 19, 2024, the NADAC for MIRABEGRON ER 50 MG TABLET has ranged from a low of $8.9858 (Nov 18, 2026) to a high of $11.9419 (Jul 10, 2024), with a median of $9.7353 per EA.

Are there cheaper alternatives to MIRABEGRON ER 50 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MIRABEGRON ER 50 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MIRABEGRON ER 50 MG TABLET?

MIRABEGRON ER 50 MG TABLET (NDC 70710116003) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.